Less Ads, More Data, More Tools Register for FREE

Pin to quick picksThg Regulatory News (THG)

Share Price Information for Thg (THG)

Share Price is delayed by 15 minutes
Get Live Data
33.36    0.00 (0.00%)
Bid:
33.16
Ask:
33.42
Spread: 0.26 (0.784%)
Market Cap: £529.37m
THG Live PriceLast checked at - London Stock Exchange

Intraday Thg Share Chart

Statement regarding THG plc

16 Jun 2022 07:00

RNS Number : 0570P
Belerion Capital Group Ltd
16 June 2022
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION.

 

THIS ANNOUNCEMENT IS AN ANNOUNCEMENT FALLING UNDER RULE 2.8 OF THE CITY CODE ON TAKEOVERS AND MERGERS (THE "CODE").

 

FOR IMMEDIATE RELEASE

 

 

16 June 2022

 

Belerion Capital Group Limited ("Belerion")

 

Statement regarding THG plc ("THG" or "the Company")

 

 

Belerion notes the announcement made by THG on 19 May 2022. Belerion confirms that it, together with King Street Capital Management, L.P. ("King Street") in its capacity as a source of debt and equity financing, does not intend to make an offer for the Company.

 

Accordingly, Belerion and King Street are, except with the consent of the Takeover Panel, bound by the restrictions under Rule 2.8 of the Code.

 

As is customary under Rule 2.8 of the Code, Belerion and King Street reserve the right to make or participate in an offer for THG (and / or take any other actions which would otherwise be restricted under Rule 2.8 of the Code) within the next six months following the date of this announcement:

(i) with the agreement of the board of directors of THG;

(ii) following the announcement of a firm intention to make an offer for THG by or on behalf of a third party;

(iii) following the announcement by THG of a Rule 9 waiver proposal (as described in Note 1 of the Notes on Dispensations from Rule 9 of the Code) or a reverse takeover (as defined in the Code); or

(iv) where the Takeover Panel has determined that there has been a material change of circumstances.

 

 

In accordance with Rule 26.1 of the Code, a copy of this announcement will be available (subject to certain restrictions relating to persons resident in restricted jurisdictions) on Belerion's website at www.belerioncapital.com by no later than 12 noon (London time) on the business day following the date of this announcement. The content of this website is not incorporated into, and does not form part of, this announcement.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
OFDGPURCQUPPGBA
Date   Source Headline
22nd May 20267:00 amRNSNotice of AGM
21st Apr 20267:00 amRNSTrading Statement
20th Apr 20264:45 pmRNSNotice of Q1 Trading Update
8th Apr 20267:00 amRNSAnnual Report & Accounts 2025
26th Mar 20267:00 amRNSPreliminary FY 2025 results
25th Mar 20264:54 pmRNSNotice of Results
24th Feb 20267:45 amRNSPDMR/PCA Shareholding & TR-1 Notification
12th Feb 20267:00 amRNS-RMyprotein licensing partnership with Greencore
2nd Feb 20267:00 amRNSTotal Voting Rights
27th Jan 20263:49 pmRNSTR-1: Notification of major holdings
27th Jan 20263:45 pmRNSTR-1: Notification of Major Holdings
23rd Jan 20262:52 pmRNSTR-1: Notification of Major Holdings
22nd Jan 20263:00 pmRNSApplication for Listing and Total Voting Rights
16th Jan 20267:00 amRNSChange to Board Committee Membership
13th Jan 20267:00 amRNSQ4 2025 Trading Statement
12th Jan 20264:40 pmRNSNotice of Results
2nd Jan 20267:00 amRNSTotal Voting Rights
2nd Jan 20267:00 amRNSTotal Voting Rights
19th Dec 20252:20 pmRNSTR-1: Notification of Major Holdings
19th Dec 20252:20 pmRNSTR-1: Notification of Major Holdings
16th Dec 20255:50 pmRNSTR-1: Notification of Major Holdings
9th Dec 20254:35 pmRNSTR-1: Notification of Major Holdings
9th Dec 202510:55 amRNSTR-1: Notification of Major Holdings
9th Dec 20259:15 amRNSPDMR/PCA Shareholding & TR-1 Notification
5th Dec 202510:15 amRNSDirector Declaration
5th Dec 202510:05 amRNSAdmission of Convertible Loan Shares and TVR
26th Nov 20259:45 amRNSPDMR/PCA Shareholdings
17th Nov 20257:00 amRNS-RMyprotein joins forces with Mars
3rd Nov 20257:00 amRNSBlock listing Interim Review
28th Oct 202511:14 amRNSDirector Declaration
14th Oct 20257:00 amRNSQ3 2025 Trading Statement
10th Oct 20257:00 amRNSNotice of Trading Update
19th Sep 20256:00 pmRNSOcean Wilsons
11th Sep 20257:00 amRNSInterim results for half-year ended 30 June 2025
10th Sep 20254:45 pmRNSNotice of Interim Results
5th Sep 20257:00 amRNSNotification under UKLR 6.4.9R(2)
6th Aug 20257:42 amRNSDisposal, H1 trading and Nutrition update - Amend
6th Aug 20257:00 amRNSDisposal, H1 trading and Nutrition update
9th Jul 20252:24 pmRNSChanges to Directors’ Responsibilities
25th Jun 20252:38 pmRNSResult of AGM
25th Jun 20257:00 amRNSAGM Trading Statement
5th Jun 20253:56 pmRNSTR-1: Notification of Major Holdings
23rd May 20257:00 amRNSNotice of AGM
1st May 20257:00 amRNSBlock Listing Six Monthly Return
30th Apr 20257:00 amRNSAnnual Report & Accounts 2024
29th Apr 20257:00 amRNSFY 2024 results and Q1 trading statement
23rd Apr 20257:00 amRNSResponse to media speculation
16th Apr 20254:45 pmRNSTR-1: Notification of Major Holdings
4th Apr 202510:30 amRNSTR-1: Notification of Major Holdings
4th Apr 20257:00 amRNSCompletion of debt refinancing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.